Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaecheol Lee

Showing results (31-40 of 56) with videos related to

Pageof 6
Sort By:
Nano Letters|July 20, 2023
Peptide-Assembled Single-Chain Atomic Crystal Enhances Pluripotent Stem Cell Differentiation to NeuronsNam Hyeong Kim, Sudong Chae, Sang Ah Yi, et al.
Nature Biomedical Engineering|September 29, 2018
Transcriptomic and epigenomic differences in human induced pluripotent stem cells generated from six reprogramming methodsJared M Churko, Jaecheol Lee, Mohamed Ameen, et al.
Molecules (Basel, Switzerland)|September 28, 2021
Transcriptomics-Based Repositioning of Natural Compound, Eudesmin, as a PRC2 ModulatorSang Ah Yi, Ki Hong Nam, Min Gyu Lee, et al.
Nature|June 9, 2020
The effect of large-scale anti-contagion policies on the COVID-19 pandemicSolomon Hsiang, Daniel Allen, Sébastien Annan-Phan, et al.
Nature|August 23, 2020
Publisher Correction: The effect of large-scale anti-contagion policies on the COVID-19 pandemicSolomon Hsiang, Daniel Allen, Sébastien Annan-Phan, et al.
Scientific Reports|September 2, 2021
Author Correction: Human WRN is an intrinsic inhibitor of progerin, abnormal splicing product of lamin ASo-Mi Kang, Min-Ho Yoon, Su-Jin Lee, et al.
Scientific Reports|April 28, 2021
Human WRN is an intrinsic inhibitor of progerin, abnormal splicing product of lamin ASo-Mi Kang, Min-Ho Yoon, Su-Jin Lee, et al.
Arthritis Research & Therapy|February 5, 2014
Generation of disease-specific induced pluripotent stem cells from patients with rheumatoid arthritis and osteoarthritisJaecheol Lee, Youngkyun Kim, Hyoju Yi, et al.
European Heart Journal|June 21, 2019
Modelling diastolic dysfunction in induced pluripotent stem cell-derived cardiomyocytes from hypertrophic cardiomyopathy patientsHaodi Wu, Huaxiao Yang, June-Wha Rhee, et al.
BMC Cancer|August 8, 2019
Identification of a novel S6K1 inhibitor, rosmarinic acid methyl ester, for treating cisplatin-resistant cervical cancerKi Hong Nam, Sang Ah Yi, Gibeom Nam, et al.
Pageof 6

Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
Nano Letters|July 20, 2023
Peptide-Assembled Single-Chain Atomic Crystal Enhances Pluripotent Stem Cell Differentiation to NeuronsNam Hyeong Kim, Sudong Chae, Sang Ah Yi, et al.
Nature Biomedical Engineering|September 29, 2018
Transcriptomic and epigenomic differences in human induced pluripotent stem cells generated from six reprogramming methodsJared M Churko, Jaecheol Lee, Mohamed Ameen, et al.
Molecules (Basel, Switzerland)|September 28, 2021
Transcriptomics-Based Repositioning of Natural Compound, Eudesmin, as a PRC2 ModulatorSang Ah Yi, Ki Hong Nam, Min Gyu Lee, et al.
Nature|June 9, 2020
The effect of large-scale anti-contagion policies on the COVID-19 pandemicSolomon Hsiang, Daniel Allen, Sébastien Annan-Phan, et al.
Nature|August 23, 2020
Publisher Correction: The effect of large-scale anti-contagion policies on the COVID-19 pandemicSolomon Hsiang, Daniel Allen, Sébastien Annan-Phan, et al.
Scientific Reports|September 2, 2021
Author Correction: Human WRN is an intrinsic inhibitor of progerin, abnormal splicing product of lamin ASo-Mi Kang, Min-Ho Yoon, Su-Jin Lee, et al.
Scientific Reports|April 28, 2021
Human WRN is an intrinsic inhibitor of progerin, abnormal splicing product of lamin ASo-Mi Kang, Min-Ho Yoon, Su-Jin Lee, et al.
Arthritis Research & Therapy|February 5, 2014
Generation of disease-specific induced pluripotent stem cells from patients with rheumatoid arthritis and osteoarthritisJaecheol Lee, Youngkyun Kim, Hyoju Yi, et al.
European Heart Journal|June 21, 2019
Modelling diastolic dysfunction in induced pluripotent stem cell-derived cardiomyocytes from hypertrophic cardiomyopathy patientsHaodi Wu, Huaxiao Yang, June-Wha Rhee, et al.
BMC Cancer|August 8, 2019
Identification of a novel S6K1 inhibitor, rosmarinic acid methyl ester, for treating cisplatin-resistant cervical cancerKi Hong Nam, Sang Ah Yi, Gibeom Nam, et al.
Pageof 6